-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Doximity, Lowers Price Target to $38

Benzinga·02/11/2026 14:11:09
Listen to the news
Barclays analyst Glen Santangelo maintains Doximity (NYSE:DOCS) with a Overweight and lowers the price target from $63 to $38.